Swiss Neonatal Network & Follow-up Group
Recruiting
Observational Study
Very Low Birth Weight Infant
Very Preterm Maturity of Infant
Asphyxia Neonatorum
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 Days – 28 Days
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Swiss Neonatal Network · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The chief aim of the Swiss Neonatal Network \& Follow-Up Group (SwissNeoNet) is to maintain and / or improve the quality and safety of medical care for high-risk newborn infants and their families in Switzerland through a coordinated program of research, education and collaborative audit. In support of its aim, SwissNeoNet hosts the official medical quality register for the Swiss level III and lev…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria of "Minimal Neonatal Dataset" (MNDS):
All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight
Inclusion criteria of "Below 34 data collection", (B34):
All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth…
Contacts